-
Attorney General Ashley Moody says the money will be spent on drug prevention measures as well as opioid treatment and recovery services.
-
Johnson & Johnson says internal testing showed some sunscreen samples contained low levels of benzene, which causes cancer with long-term exposure.
-
Of the more than 12 million people who received the Johnson & Johnson vaccine, around 100 developed Guillain-Barré syndrome, according to the Centers for Disease Control and Prevention.
-
Johnson & Johnson says two small-sample lab studies that have not yet been peer-reviewed showed the one-dose shot is highly protective against the variant and that immunity may be long-lasting.
-
The New York attorney general says Johnson & Johnson has agreed to pay $230 million to settle claims that the pharmaceutical giant helped fuel the opioid crisis.
-
Johnson & Johnson says the FDA approved extending the three-month shelf life to 4 1/2 months. The extension comes as the number of U.S. vaccinations continues to slip.
-
President Biden's commitment Monday to donate doses of Moderna, Pfizer and Johnson & Johnson vaccines adds to an earlier promise of 60 million doses of AstraZeneca.
-
The Acuvue Abiliti Overnight Therapeutic Lenses, produced by Jacksonville-based Johnson & Johnson Vision, temporarily reshapes the cornea to reduce the rate of axial elongation.
-
Only slightly more first doses of Pfizer were administered at the FEMA-run vaccination sites on Monday than single-dose Johnson & Johnson shots.
-
The Johnson & Johnson shots return after federal health officials decided the vaccine’s benefits outweigh a risk of rare blood clots discovered in 15 of nearly 8 million recipients.